D J Judah

Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.

Lesley M. Forrester, G.E. Neal, D J Judah et al. · Proceedings of the National Academy of Sciences · 1990 · 197 citations

Premature Death, Iron Metabolism, Pathology +25

Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.

Vincent P. Kelly, Elizabeth M. Ellis, Margaret M. Manson et al. · PubMed · 2000 · 146 citations

Pathology, Redox Biology, Toxicological Mechanism +19

Metabolism and Toxicity of Aflatoxins M1and B1in Human-Derivedin VitroSystems

G.E. Neal, David L. Eaton, D J Judah et al. · Toxicology and Applied Pharmacology · 1998 · 139 citations

Biochemistry, Mycotoxin Formation, Bioanalysis +7

An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.

Elizabeth M. Ellis, D J Judah, G.E. Neal et al. · Proceedings of the National Academy of Sciences · 1993 · 124 citations

Aldo-keto Reductase, Ethoxyquin-inducible Aldehyde Reductase, Redox Biology +18

Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance

Nicola J. Turton, D J Judah, Joan Riley et al. · Oncogene · 2001 · 123 citations

Breast Oncology, Doxorubicin Resistance, Oncogenic Agent +8